TOL19-001

**TOL19-001** is a multi-ingredient oral dietary supplement marketed by Labrha as **Cicatendon** and subsequently as **Tenofort** for tendon health and tendinopathy. The capsule formulation contains spirulina, D-glucosamine sulfate, horsetail extract, ginseng, selenium, vitamin E, ferrous gluconate, and zinc gluconate. In cultured tendon-cell models exposed to interleukin-1β or ciprofloxacin, TOL19-001 reduced prostaglandin E2 production, matrix metalloproteinase expression, and type III collagen-associated changes, consistent with a broad anti-inflammatory and antioxidant effect rather than a defined single-target pharmacologic mechanism. Published clinical evidence includes an observational survey in patients with long-term tendinopathy; randomized controlled studies were stated to be needed. ([labrha-international.com](https://labrha-international.com/cicatendon-reduces-inflammation-and-mmp-expression-in-monolayer-cultures-of-tendon-cells-read-our-recent-publication-in-bmc-complementary-and-alternative-medicine/))

Brand names

CicatendonTenofort

Other names

TOL-19-001TOL19-001TOL 19-001